Yunpeng Liu

机构：Jilin University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Laboratory Animal Science, Jilin Medical University · ORCID：0000-0003-1398-0872

发表论文 56 篇 · 总被引 967 次 · h-index 14

代表论文

• Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer (2024 · JAMA · 被引 361)
• The Role of Tumor Stem Cell Exosomes in Cancer Invasion and Metastasis (2022 · Frontiers in Oncology · 被引 41)
• [Retracted] miR‑154 inhibits migration and invasion of human non‑small cell lung cancer by targeting ZEB2 (2021 · Oncology Letters · 被引 40)
• Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial (2022 · Journal of Cancer Research and Clinical Oncology · 被引 39)
• Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial (2024 · EClinicalMedicine · 被引 23)
• Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320 (2021 · Journal of Pharmacy and Pharmacology · 被引 16)